Enliven Therapeutics, Inc. (ELVN)

Enliven Therapeutics Statistics

Total Valuation

ELVN has a market cap or net worth of $1.04 billion. The enterprise value is $754.65 million.

Market Cap	1.04B
Enterprise Value	754.65M

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025, after market close.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	n/a

Share Statistics

ELVN has 58.99 million shares outstanding. The number of shares has increased by 18.45% in one year.

Current Share Class	58.99M
Shares Outstanding	58.99M
Shares Change (YoY)	+18.45%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	4.33%
Owned by Institutions (%)	55.25%
Float	36.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.01
P/TBV Ratio	3.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.06, with a Debt / Equity ratio of 0.00.

Current Ratio	21.06
Quick Ratio	20.72
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -31.30% and return on invested capital (ROIC) is -22.71%.

Return on Equity (ROE)	-31.30%
Return on Assets (ROA)	-21.36%
Return on Invested Capital (ROIC)	-22.71%
Return on Capital Employed (ROCE)	-38.21%
Revenue Per Employee	n/a
Profits Per Employee	-$1.53M
Employee Count	62
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ELVN has paid $232,000 in taxes.

Income Tax	232,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.74% in the last 52 weeks. The beta is 1.03, so ELVN's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	-18.74%
50-Day Moving Average	20.71
200-Day Moving Average	21.59
Relative Strength Index (RSI)	34.68
Average Volume (20 Days)	398,429

Short Selling Information

The latest short interest is 5.54 million, so 9.40% of the outstanding shares have been sold short.

Short Interest	5.54M
Short Previous Month	6.13M
Short % of Shares Out	9.40%
Short % of Float	15.16%
Short Ratio (days to cover)	8.86

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-110.26M
Pretax Income	-79.60M
Net Income	-94.83M
EBITDA	-109.95M
EBIT	-110.26M
Earnings Per Share (EPS)	-$1.93

Balance Sheet

The company has $289.56 million in cash and $667,000 in debt, giving a net cash position of $288.89 million or $4.90 per share.

Cash & Cash Equivalents	289.56M
Total Debt	667,000
Net Cash	288.89M
Net Cash Per Share	$4.90
Equity (Book Value)	288.30M
Book Value Per Share	5.88
Working Capital	280.35M

Cash Flow

In the last 12 months, operating cash flow was -$73.96 million and capital expenditures -$44,000, giving a free cash flow of -$74.00 million.

Operating Cash Flow	-73.96M
Capital Expenditures	-44,000
Free Cash Flow	-74.00M
FCF Per Share	-$1.25

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELVN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.45%
Shareholder Yield	-18.45%
Earnings Yield	-9.09%
FCF Yield	-7.09%

Analyst Forecast

The average price target for ELVN is $41.20, which is 133.96% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$41.20
Price Target Difference	133.96%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-5.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2